Fenwal Receives FDA Clearance for Therapeutic Plasma Exchange on Its Amicus® Separator

Published: Apr 02, 2012

LAKE ZURICH, Ill.--(BUSINESS WIRE)--The U.S. Food and Drug Administration has cleared Fenwal to market a therapeutic plasma exchange protocol for the company’s Amicus® separator, Fenwal announced today.

Back to news